Your search resulted in 1 documents.
Development process of a new anti-sapstain formulation and its present status with the relevant problems
2001 - IRG/WP 01-30257
An anti-sapstain formulation, which contains 2-(thiocyanomethylthio)benzothiazol (TCMTB) and methylene-bis-thiocyanate (MBT) as active ingredients, was developed by a technical agreement with Buckman Laboratories (Memphis, TN, USA) as an alternative to chlorinated phenols for the Japanese market. The formulation was commercialized as BAM 12 years ago. As anti-sapstain treatment is commonly conduct...
K Nobashi, Y Nomura, K Tsunoda